New studies indicate that Lecanemab , an cutting-edge drug, has the potential to slow the development of early-stage cognitive decline. This treatment works by clearing amyloid plaques in the https://gorillasocialwork.com/story26824051/donanemab-an-promising-novel-alzheimer-s-treatment